ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1225

Sphygmomanometry for Fibromyalgia Detection in a Rheumatology Outpatient Clinic. a Cross-sectional Study

Viridiana Del Río Guerrero1, Laura Aline Martínez Martínez1, Karina Arias Callejas1, Natalia Carbonell-Bobadilla2, Alejandra Mejía Segura1, Gibrán Azamar Morales1, Alejandra Espinosa Orantes1, Mauricio Mora Ramírez1, Fernanda Mejía Ávila1, Raúl Molina Sánchez1, Angélica Vargas-Guerrero1, Luis H Silveira1 and Manuel Martínez-Lavín3, 1Instituto Nacional de Cardiología, Ciudad de México, Mexico, 2National Institute of Cardiology Ignacio Chávez, Ciudad de México, Mexico, 3Instituto Nacional de Cardiología Ignacio Chávez, Ciudad de México, Mexico

Meeting: ACR Convergence 2022

Keywords: fibromyalgia, gender, pain

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 13, 2022

Title: Fibromyalgia and Other Clinical Pain Syndromes Poster

Session Type: Poster Session C

Session Time: 1:00PM-3:00PM

Background/Purpose: Allodynia is a key fibromyalgia (FM) feature. Women suffering from FM display more often sphygmomanometry-elicited allodynia when compared to women with osteoarthritis, rheumatoid arthritis or healthy controls [1]. The importance of recognizing FM in a Rheumatology clinic cannot be overstated. FM overlaps and/or mimics other rheumatic diseases and may be a confounding factor in the clinimetric assessment of these illnesses. Proper FM diagnosis leads to more effective multimodal therapy. For epidemiological purposes FM can now be identified using the 2016 Wolfe et al FM diagnostic criteria questionnaire.

Sphygmomanometry is a simple mandatory test in all clinical settings. The objective of this cross-sectional study was to define if sphygmomanometry is a useful screening tool for FM identification in a Rheumatology outpatient clinic.

Methods: All patients attending our adult Rheumatology outpatient clinic were invited to participate. Before their medical consultation they filled-out the 2016 Wolfe et al FM diagnostic criteria questionnaire. Then a Rheumatologist-in-training, unaware of the questionnaire calculation, performed the routine medical visit. During physical examination the following query was posed to all patients: “I am going to take your blood pressure, tell me if the cuff´s pressure brings forth pain”. Blood pressure cuff was inflated to 170 mm/Hg. Sphygmomanometry-induced allodynia was defined as any local discomfort elicited during blood pressure testing. If a patient voiced any discomfort, a follow-up dichotomic question ensued; “did it hurt much or little”.

Results: Of the first 268 studied patients, 215 (80.2%) were female. Female cohort displayed the following features; 24.3% had FM according to Wolfe et al 2016 diagnostic criteria, 23.8% had sphygmomanometry-induced allodynia, 7.5% had “much” local pain elicitation during blood pressure testing. Sphygmomanometry-induced allodynia was more frequent in women with FM (55.8%) versus women without FM (13.6%) p = 0.0001. Sphygmomanometry-evoked allodynia had 56% sensitivity and 86% specificity for FM diagnosis. Moreover, having “much” local pain elicitation during sphygmomanometry had 97.1% specificity for FM diagnosis.

Men behaved differently; 18.9% fulfilled FM diagnostic criteria, but only 1.9% had sphygmomanometry-evoked allodynia.

Conclusion: In this Rheumatology outpatient clinic, there was an unexpected high FM prevalence. Inquiring female patients for local discomfort during sphygmomanometry is a simple helpful FM screening procedure that can be implemented in all clinical settings. Substantial local pain elicitation during blood pressure testing strongly indicates the presence of FM.


Disclosures: V. Del Río Guerrero, None; L. Martínez Martínez, None; K. Arias Callejas, None; N. Carbonell-Bobadilla, None; A. Mejía Segura, None; G. Azamar Morales, None; A. Espinosa Orantes, None; M. Mora Ramírez, None; F. Mejía Ávila, None; R. Molina Sánchez, None; A. Vargas-Guerrero, None; L. Silveira, None; M. Martínez-Lavín, None.

To cite this abstract in AMA style:

Del Río Guerrero V, Martínez Martínez L, Arias Callejas K, Carbonell-Bobadilla N, Mejía Segura A, Azamar Morales G, Espinosa Orantes A, Mora Ramírez M, Mejía Ávila F, Molina Sánchez R, Vargas-Guerrero A, Silveira L, Martínez-Lavín M. Sphygmomanometry for Fibromyalgia Detection in a Rheumatology Outpatient Clinic. a Cross-sectional Study [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/sphygmomanometry-for-fibromyalgia-detection-in-a-rheumatology-outpatient-clinic-a-cross-sectional-study/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/sphygmomanometry-for-fibromyalgia-detection-in-a-rheumatology-outpatient-clinic-a-cross-sectional-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology